Company Filing History:
1 out of 3,685 
1 out of 832,880 Years Active: 2009-2013
Title: The Innovations of Catherine Aversa Fleener
Introduction
Catherine Aversa Fleener is a notable inventor based in Holland, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, her work has implications for medical research and therapeutic applications.
Latest Patents
Catherine's latest patents include innovative methods for assaying the binding of L104EA29YIg to receptors, specifically CD86 and CD80. The first patent discloses a method for this binding assay, along with antibodies and hybridomas expressing these antibodies. The second patent also focuses on CD86 and CD80 receptor competition assays, further enhancing the understanding of these critical receptors in immunology.
Career Highlights
Throughout her career, Catherine has worked with prominent companies, including Bristol-Myers Squibb Company. Her experience in such a reputable organization has allowed her to refine her skills and contribute to groundbreaking research in her field.
Collaborations
Catherine has collaborated with esteemed colleagues, including Robert Martin Townsend and Francisco A Leon. These partnerships have likely enriched her research and expanded the impact of her inventions.
Conclusion
Catherine Aversa Fleener's contributions to biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical research and therapeutic solutions.